Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Charles Bennett, MD, PhD, MPP, Eleasa vanSlooten, Matthew Bialkowski, Alyssa Trenery, Ashlyn Byrne, Alanna Murday, BS, Paul Yarnold, Zaina Parvez Qureshi, PhD, MPH, A. Oliver Sartor, MD

Blood (2012) 120 (21): 4695.

https://doi.org/10.1182/blood.V120.21.4695.4695

Published: 2012

Journal Articles

Cocaine-Levamisole Thrombovasculopathy: A Report From the Southern Network On Adverse Reactions (SONAR) Project

Charles Bennett, MD, PhD, MPP, Irene Dy, Peter Wiernik, MD, Jennie Buchanan, Richard Dart, Brian Edlin, Erin Gilbert, Priya Mahindra, Alanna Murday, BS, Zaina Parvez Qureshi, PhD, MPH

Blood (2012) 120 (21): 3403.

https://doi.org/10.1182/blood.V120.21.3403.3403

Published: 2012

Journal Articles

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Charles Bennett, MD, PhD, MPP, Masanori Matsumoto, MD, Peter Georgantopoulos, MPH, AM, Sony Jacob, MD, Brianne L Dunn, PharmD, Zaina Parvez Qureshi, PhD, MPH, Nicholas Bandarenko, III, MD, Hau C. Kwaan, MD, PhD, Jeffrey Winters, MD, Ravindra Sarode, MD, Joseph E Kiss, MD, Constance Danielson, MD, PhD, Thomas L. Ortel, MD, PhD, Thomas Raife, MD, William F Clark, MD, Gail Rock, PhD, MD, FRCP, X. Long Zheng, MD, PhD, Dennis Raisch, Ph.D., M.S., R.Ph., Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 2203.

https://doi.org/10.1182/blood.V120.21.2203.2203

Published: 2012

Journal Articles

Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse

Zhiqiang Lu, Zaina Parvez Qureshi, PhD, MPH, Brian Chen, Sudha Xirasagar, Paul Ray, Gowtham Rao, Isaac Lopez, Tisha Felder, Richard Ablin, Oliver Sartor, MD, Charles Bennett, MD, PhD, MPP

Blood (2012) 120 (21): 4275.

https://doi.org/10.1182/blood.V120.21.4275.4275

Published: 2012

Journal Articles

First Estimates of Incidence of Progressive Multifocal Leukoencephalopathy Developing Among 10,459 Non-HIV Lymphoma VA Patients Who Receive Rituximab: Results From the Veterans Administration Database (1999–2012).

Gowtham Rao, MD, PhD, Peter Georgantopoulos, MPH, AM, Kathlyn Sue Haddock, RN, PhD, Kenneth R. Carson, MD, LeAnn Norris, PharmD, Oliver Sartor, MD, Charles Bennett, MD, PhD, MPP

Blood (2012) 120 (21): 2752.

https://doi.org/10.1182/blood.V120.21.2752.2752

Published: 2012

Journal Articles

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

Ayami Isonishi, BS, Masanori Matsumoto, MD, PhD, Friedrich Scheiflinger, PhD, Barbara Plaimauer, PhD, Charles Bennett, MD, PhD, MPP, Yoshihiro Fujimura, MD, PhD

Blood (2012) 120 (21): 1086.

https://doi.org/10.1182/blood.V120.21.1086.1086

Published: 2012

Journal Articles

Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty Year Review

Zaina Parvez Qureshi, PhD, MPH, John Armstrong, PhD, Charles Bennett, MD, PhD, MPP

Blood (2011) 118 (21): 2226.

https://doi.org/10.1182/blood.V118.21.2226.2226

Published: 2011

Journal Articles

Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)

Leann Norris, PharmD, Donald Mattison, M.D., CAPT, USPHS, Zaina Parvez Qureshi, PhD, MPH, Charles Bennett, MD, PhD, MPP

Blood (2011) 118 (21): 4753.

https://doi.org/10.1182/blood.V118.21.4753.4753

Published: 2011

Journal Articles

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

Charles Bennett, MD, PhD, MPP, Leann Norris, PharmD, Zaina Parvez Qureshi, PhD, MPH, April Miller, PharmD, Brandon Bookstaver, PharmD, BCPS (AQ-ID), AAHIVE, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4756.

https://doi.org/10.1182/blood.V118.21.4756.4756

Published: 2011

Journal Articles

The Importance of Press Releases Describing ASH Conference Findings in Translating Research Into Policy: Case Study and Seven-Year Follow-up From a 2004 Oral Presentation

Charles Bennett, MD, PhD, MPP, Adam Kahn, Zaina Parvez Qureshi, PhD, MPH, Sudha Xirasagar, MBBS, PhD, Donald Mattison, M.D., CAPT, USPHS

Blood (2011) 118 (21): 4766.

https://doi.org/10.1182/blood.V118.21.4766.4766

Published: 2011

Journal Articles

Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine

Charles Bennett, MD, PhD, MPP, Zaina Qureshi, PhD, MPH

Blood (2010) 116 (21): 1527.

https://doi.org/10.1182/blood.V116.21.1527.1527

Published: 2010

Journal Articles

Racial/Ethnic Disparities of Erythropoiesis Stimulating Agent Use Among the Insured Poor: Pre- and Post-Safety Advisories

Dana Stafkey-Mailey, PharmD, PhD, Charles Bennett, MD, PhD, MPP, Michael Dickson, RPh, PhD

Blood (2010) 116 (21): 395.

https://doi.org/10.1182/blood.V116.21.395.395

Published: 2010

Journal Articles

Hematologic Abnormalities Following Crotaline Snakebites In South Carolina

Zaina Qureshi, PhD, MPH, Jill Michels, PharmD, Zach Kiker, MD, Charles Bennett, MD, PhD, MPP, William Richardson, MD

Blood (2010) 116 (21): 4753.

https://doi.org/10.1182/blood.V116.21.4753.4753

Published: 2010

Journal Articles

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

LeAnn Norris, PharmD, Zaina Qureshi, PhD, MPH, Sara Barnato, Stephen Lai, MD, PhD, Charles Bennett, MD, PhD, MPP

Blood (2010) 116 (21): 2555.

https://doi.org/10.1182/blood.V116.21.2555.2555

Published: 2010

Journal Articles

Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.

Veena Shankaran, MD, June McKoy, MD, MPH, JD, Ben Djulbegovic, MD, PhD, Allison Lyons, BA, Ken Carson, MD, Cara Tigue, BA, Neal Dandade, BA, Martin Tallman, MD, Oliver Sartor, MD, Charles Bennett, MD, PhD, MPP

Blood (2007) 110 (11): 3340.

https://doi.org/10.1182/blood.V110.11.3340.3340

Published: 2007

NARROW

Evaluating Conflicts of Interest in Academic Research On Erythropoietin Receptors in the Cancer Setting

Cocaine-Levamisole Thrombovasculopathy: A Report From the Southern Network On Adverse Reactions (SONAR) Project

Deficient ADAMTS13 Activity in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura (TTP) in Populations From Japan in 2012: Validation of Findings Initially Reported in the United States in 1998 and 2000.

Why Is Cancer Care So Expensive: Potential Implications of Fraud and Abuse

First Estimates of Incidence of Progressive Multifocal Leukoencephalopathy Developing Among 10,459 Non-HIV Lymphoma VA Patients Who Receive Rituximab: Results From the Veterans Administration Database (1999–2012).

Anti-ADAMTS13 Inhibitor Boosting During Plasma Exchange Therapy Often Causes an Intractable Acquired Idiopathic TTP

Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty Year Review

Location, Location, Location: Reassessing Erythropoiesis Stimulating Agents (ESAs) in the United States (US), Canada, and Europe (2007−2011)

Translating Research Into Policy: A Review of Pharmacovigilance Efforts From the Southern Network On Adverse Reactions (SONAR) Group

The Importance of Press Releases Describing ASH Conference Findings in Translating Research Into Policy: Case Study and Seven-Year Follow-up From a 2004 Oral Presentation

Finishing the Picture: Clopidogrel Is Indeed the Most Common Drug Associated with Thrombotic Thrombocytopenic Purpura (TTP) In FDA Databases: Its Mechanism, Laboratory Findings, Clinical Features, and Epidemiology Differ From That Associated with Ticlopidine

Racial/Ethnic Disparities of Erythropoiesis Stimulating Agent Use Among the Insured Poor: Pre- and Post-Safety Advisories

Hematologic Abnormalities Following Crotaline Snakebites In South Carolina

Serious Adverse Drug Reactions (sADRS) Associated with Hematopoietic Growth Factors: A Systematic Review From the Southern Network on Adverse Reactions (SONAR) Program

Waiting for Godot: Thirty-Six Month Follow-Up on Accelerated FDA Approval of Drugs To Treat Hematologic Malignancies.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only